Combined enzyme/prodrug treatment by genetically engineered AT-MSC exerts synergy and inhibits growth of MDA-MB-231 induced lung metastases / Matúšková, M. ... [et al.]. -- Popis urobený z citácie

In Journal of experimental & clinical cancer research : CR. -- Vol. 34, no. 1 (2015), s. 33

I. Matúšková, Miroslava
II. Kozovská, Zuzana
III. Toro, Lenka
IV. Ďuriníková, Erika
V. Tyčiaková, Silvia
VI. Journal of experimental & clinical cancer research : CR. -- Vol. 34, no. 1 (2015), s. 33